UnknownNot applicableNCT06200727

Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Lei Du
Principal Investigator
Lei Du, MD
Renmin Hospital of Wuhan University
Intervention
PRF membrane tamponade surgery in macular hole(procedure)
Enrollment
170 target
Eligibility
20-90 years · All sexes
Timeline
20232025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06200727 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials